October 01, 2014 4:35 PM ET

Biotechnology

Company Overview of GelTex Pharmaceuticals, Inc.

Company Overview

As of December 14, 2000, GelTex Pharmaceuticals, Inc. was acquired by Genzyme Corp. GelTex Pharmaceuticals, Inc. is engaged in developing and marketing non-absorbed polymer drugs that bind and eliminate targeted substances within the gastrointestinal tract, as of September 30, 2000. In addition, GelTex is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators. Therapeutic areas of interest included hyperphosphatemia, hypercholesterolemia, cancer, iron overload, and infectious diseases. The company is based in Waltham Massachusetts.

153 Second Avenue

Waltham, MA 02451

United States

112 Employees

Phone:

781-290-5888

Key Executives for GelTex Pharmaceuticals, Inc.

GelTex Pharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Medtronic Transneuronix, Inc. United States
Clinical Data, Inc. United States
International Oilseed Distributors, Inc. United States
Promedior, Inc. United States
Advanced Microbotics Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GelTex Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.